{"id":23705,"date":"2025-10-02T08:53:41","date_gmt":"2025-10-02T05:53:41","guid":{"rendered":"https:\/\/canatu.com\/?post_type=event&p=23705"},"modified":"2025-10-03T14:47:25","modified_gmt":"2025-10-03T11:47:25","slug":"adlm-2026","status":"publish","type":"event","link":"https:\/\/canatu.com\/company\/events\/adlm-2026\/","title":{"rendered":"ADLM 2026"},"content":{"rendered":"\n

Visit Canatu at ADLM Annual Scientific Meeting & Clinical Lab Expo (formerly AACC)<\/strong> July 28\u201330, 2026 | Anaheim Convention Center, Anaheim, CA | Booth #1304<\/strong><\/p>\n\n\n\n

Canatu will present its electrochemical biosensors<\/a> for medical diagnostics<\/a><\/strong>, built on our advanced carbon nanotube<\/a> (CNT) technology<\/strong>. These sensors deliver more than a 10-fold increase in sensitivity<\/strong> in vitro matrices. This exceptional sensitivity is achieved through our patented dry deposition<\/a><\/strong> process, yielding CNTs with pristine, high-surface-area.

This exceptional sensitivity unlocks unprecedented detection capabilities for new assays. Furthermore, severe infections and diseases, like cancer, can now be detected at an early stage, saving lives and money.<\/p>\n\n\n\n

Our proprietary click chemistry<\/strong> enables the immobilization of virtually any analyte of interest, including antibodies, DNAs, enzymes, and aptamers, making it a versatile platform technology for detecting any analyte of interest. This offers an unprecedented opportunity to detect severe diseases and infections at their earliest stages.

Canatu has the experience and expertise to produce tens of millions of sensors every year. Our patented dry deposition method and electrode patterning process are fully compatible with roll-to-roll production and have been successfully demonstrated at an industrial scale<\/strong>. We have been mass-producing our sensors for multiple industries since 2015.<\/p>\n\n\n\n

Key benefits of electrochemical biosensors:<\/strong><\/p>\n\n\n\n